BrainCells this week announced the addition of Seth Goldblum as vice president of business development. Goldblum is responsible for evaluating in-licensing and collaboration opportunities for compounds that promote neurogenesis for central nervous system indications. Goldblum reports to CEO James Schoeneck.
Prior to joining BCI, Goldblum was head of business development for Senomyx. Before that, he served in executive positions with Vical.